Key facts
- This page summarizes Douglas R. Baum's Form 4 filing for QSAM Biosciences, Inc..
- 1 reported transaction and 3 derivative rows are listed below.
- Accepted by SEC: 23 Jun 2023, 16:30.
Douglas R. Baum - 23 Jun 2023 Form 4 Insider Report for QSAM Biosciences, Inc.
- Reporting relationship
- CEO/Director, Director
- Issuer ticker
- N/A
- Reported as of
- 23 Jun 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 23 Jun 2023, 16:30:38 UTC
- Prior SEC filing
- 04 Jan 2023
- Next SEC filing
- 14 Feb 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Douglas R. Baum
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Douglas R. Baum filed Form 4 for QSAM Biosciences, Inc. on 23 Jun 2023.
Change
- Previous filing in this sequence was filed on 04 Jan 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
QSAM
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +72,276
- Change %
- +24%
- Price
- $0.000000
- Shares after
- 375,547
- Date
- 23 Jun 2023
- Ownership
- Direct
- Footnotes
- F1
QSAM
holding
Series B
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 684
- Date
- 23 Jun 2023
- Ownership
- Direct
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
QSAM
holding
Derivative
Options to buy common stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 12,500
- Date
- 23 Jun 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 12,500
- Exercise price
- $10.00
- Footnotes
- F3
QSAM
holding
Derivative
Options to buy common stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 200
- Date
- 23 Jun 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 200
- Exercise price
- $20.00
- Footnotes
- F4
QSAM
holding
Derivative
Options to buy common stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 3,125
- Date
- 23 Jun 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,125
- Exercise price
- $14.40
- Footnotes
- F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
This award of shares is being made pursuant to the Issuer's restricted stock award agreement and is subject to a vesting schedule, such that a portion or all of this award of restricted stock may be forfeited in the future if certain milestones are not met.
Footnote F2
Represents shares of Common Stock receivable upon conversion of Series B Preferred Stock at a conversion rate of $5.42 per share, and includes accrued dividends as of 05/31/2023.
Footnote F3
The option vests annually in two equal installments beginning on 3/3/2023.
Footnote F4
The option vests annually in two equal installments beginning on 1/14/2021.
Footnote F5
The option vests semi-annually in two equal installments beginning on 2/24/2022